Paper37446271
Propranolol, Promising Chemosensitizer and Candidate for the Combined Therapy through Disruption of Tumor Microenvironment Homeostasis by Decreasing the Level of Carbonic Anhydrase IX.
Puzderova B and 7 others. Int J Mol Sci, 2023. Cited by 20 papers, by iCite.
Cite this record
ConductScience Library. Propranolol, Promising Chemosensitizer and Candidate for the Combined Therapy through Disruption of Tumor Microenvironment Homeostasis by Decreasing the Level of Carbonic Anhydrase IX. Papers, record 37446271. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37446271
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Propranolol, Promising Chemosensitizer and Candidate for the Combined Therapy through Disruption of Tumor Microenvironment Homeostasis by Decreasing the Level of Carbonic Anhydrase IX.
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Propranolol | Major topic |
| Neoplasms | Major topic |
| Humans | |
| Animals | |
| Mice | |
| Carbonic Anhydrase IX | |
| Tumor Microenvironment | |
| Antigens, Neoplasm | |
| Fluorouracil | |
| Cell Line, Tumor |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| APVV-20-0485 | Research & Developmental Support Agency | PubMed | ||
| VEGA 2/090/20 | Slovak Scientific Grant Agency | PubMed | ||
| IMTS: 313011V446 | Operational Programme Integrated Infrastructure for the project: Integrative strategy in devel-opment of personalized medicine of selected malignant tumors and its impact on quality of life | PubMed |
Source PubMed
References63
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 10631692 | The use of thymidylate synthase inhibitors in the treatment of advanced colorectal cancer: current status. | Oncologist | 1999 | https://conductscience.org/library/papers/10631692 | PubMed |
| 2 | 31540045 | Improving Cancer Immunotherapy by Targeting the Hypoxic Tumor Microenvironment: New Opportunities and Challenges. | Cells | 2019 | https://conductscience.org/library/papers/31540045 | PubMed |
| 3 | 15556624 | Hypoxia activates the capacity of tumor-associated carbonic anhydrase IX to acidify extracellular pH. | FEBS Lett | 2004 | https://conductscience.org/library/papers/15556624 | PubMed |
| 4 | 22807646 | Beta blockers, norepinephrine, and cancer: an epidemiological viewpoint. | Clin Epidemiol | 2012 | https://conductscience.org/library/papers/22807646 | PubMed |
| 5 | 21094927 | Biobehavioral influences on cancer progression. | Immunol Allergy Clin North Am | 2011 | https://conductscience.org/library/papers/21094927 | PubMed |
| 6 | 25098269 | FAK in cancer: mechanistic findings and clinical applications. | Nat Rev Cancer | 2014 | https://conductscience.org/library/papers/25098269 | PubMed |
| 7 | 16508637 | FOLFOXIRI (folinic acid, 5-fluorouracil, oxaliplatin and irinotecan) vs FOLFIRI (folinic acid, 5-fluorouracil and irinotecan) as first-line treatment in metastatic colorectal cancer (MCC): a multicentre randomised phase III trial from the Hellenic Oncology Research Group (HORG). | Br J Cancer | 2006 | https://conductscience.org/library/papers/16508637 | PubMed |
| 8 | 27308436 | Role of the autonomic nervous system in tumorigenesis and metastasis. | Mol Cell Oncol | 2015 | https://conductscience.org/library/papers/27308436 | PubMed |
| 9 | 8178713 | Regulation of thymidylate synthase in human colon cancer cells treated with 5-fluorouracil and interferon-gamma. | Adv Exp Med Biol | 1993 | https://conductscience.org/library/papers/8178713 | PubMed |
| 10 | 11156414 | Hypoxia-inducible expression of tumor-associated carbonic anhydrases. | Cancer Res | 2000 | https://conductscience.org/library/papers/11156414 | PubMed |
| 11 | 35956154 | Propranolol: A "Pick and Roll" Team Player in Benign Tumors and Cancer Therapies. | J Clin Med | 2022 | https://conductscience.org/library/papers/35956154 | PubMed |
| 12 | 36067803 | Long-term resistance to 5-fluorouracil promotes epithelial-mesenchymal transition, apoptosis evasion, autophagy, and reduced proliferation rate in colon cancer cells. | Eur J Pharmacol | 2022 | https://conductscience.org/library/papers/36067803 | PubMed |
| 13 | 21833026 | Dysregulated pH: a perfect storm for cancer progression. | Nat Rev Cancer | 2011 | https://conductscience.org/library/papers/21833026 | PubMed |
| 14 | 36604116 | Global burden of colorectal cancer in 2020 and 2040: incidence and mortality estimates from GLOBOCAN. | Gut | 2023 | https://conductscience.org/library/papers/36604116 | PubMed |
| 15 | 9748116 | The relationship between high-dose treatment and combination chemotherapy: the concept of summation dose intensity. | Clin Cancer Res | 1998 | https://conductscience.org/library/papers/9748116 | PubMed |
| 16 | 11705873 | Characterization of a thymidylate synthase (TS)-inducible cell line: a model system for studying sensitivity to TS- and non-TS-targeted chemotherapies. | Clin Cancer Res | 2001 | https://conductscience.org/library/papers/11705873 | PubMed |
| 17 | 26772662 | Pharmacologic Interventions for Infantile Hemangioma: A Meta-analysis. | Pediatrics | 2016 | https://conductscience.org/library/papers/26772662 | PubMed |
| 18 | 32536012 | 5-Fluorouracil resistance mechanisms in colorectal cancer: From classical pathways to promising processes. | Cancer Sci | 2020 | https://conductscience.org/library/papers/32536012 | PubMed |
| 19 | 15641020 | Molecular mechanisms of drug resistance. | J Pathol | 2005 | https://conductscience.org/library/papers/15641020 | PubMed |
| 20 | 28430641 | The regulation of β-catenin activity and function in cancer: therapeutic opportunities. | Oncotarget | 2017 | https://conductscience.org/library/papers/28430641 | PubMed |
Cited by18
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 20 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42985483 | Sustained Propranolol Use and Site-Specific All-Cause Mortality after Cancer Diagnosis: A Nationwide Taiwan Cohort Study. | Oncol Res | 2026 | https://conductscience.org/library/papers/42985483 | PubMed |
| 42588722 | Targeting β-Adrenergic Signaling in Colorectal Cancer: Molecular Mechanisms and Therapeutic Potential of β-Blockers. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/42588722 | PubMed |
| 42212159 | Peripheral nerve remodeling in the tumor microenvironment: neuro-immune crosstalk, molecular mechanisms, and precision therapeutic. | Front Immunol | 2026 | https://conductscience.org/library/papers/42212159 | PubMed |
| 41866332 | Propranolol enhances the oncolytic effect of newcastle disease virus on canine mammary tumor cell by modulating the IFN-I-mediated JAK-STAT signaling pathway. | Vet Q | 2026 | https://conductscience.org/library/papers/41866332 | PubMed |
| 41509003 | Beta-Blocker Use and Survival Outcomes in Pancreatic Cancer Patients: A Systematic Review and Meta-Analysis. | Clin Med Insights Oncol | 2026 | https://conductscience.org/library/papers/41509003 | PubMed |
| 41316431 | Neural regulation of lung cancer: from mechanisms to clinical implications. | Eur J Med Res | 2025 | https://conductscience.org/library/papers/41316431 | PubMed |
| 41309043 | Beta-blocker use and survival outcomes in colorectal cancer patients: A systematic review and meta-analysis. | J Int Med Res | 2025 | https://conductscience.org/library/papers/41309043 | PubMed |
| 41256756 | Propranolol Treatment Reduces A549-Derived Lung Cancer Spheroids via Intrinsic Apoptosis. | J Clin Pract Res | 2023 | https://conductscience.org/library/papers/41256756 | PubMed |
| 41256263 | Propranolol (1 mg/kg/day) with intralesional bleomycin versus propranolol monotherapy for infantile hemangioma: a randomized controlled trial. | Front Pharmacol | 2025 | https://conductscience.org/library/papers/41256263 | PubMed |
| 41178927 | Neuro-tumor interactions: Multi-dimensional mechanisms of neurotransmitter regulation in tumor immune evasion and metabolic reprogramming. | World J Clin Oncol | 2025 | https://conductscience.org/library/papers/41178927 | PubMed |
| 40914425 | Unraveling the nexus in the neuro-neoplastic progression of colorectal cancer: Potential role of β2-adrenergic receptor (β2-AR). | J Adv Res | 2026 | https://conductscience.org/library/papers/40914425 | PubMed |
| 40842986 | Impact of beta blockers on cancer neuroimmunology: a systematic review and meta-analysis of survival outcomes and immune modulation. | Front Immunol | 2025 | https://conductscience.org/library/papers/40842986 | PubMed |
| 40361395 | Propranolol and Capecitabine Synergy on Inducing Ferroptosis in Human Colorectal Cancer Cells: Potential Implications in Cancer Therapy. | Cancers (Basel) | 2025 | https://conductscience.org/library/papers/40361395 | PubMed |
| 39640497 | The β3-Adrenergic Receptor: Structure, Physiopathology of Disease, and Emerging Therapeutic Potential. | Adv Pharmacol Pharm Sci | 2024 | https://conductscience.org/library/papers/39640497 | PubMed |
| 39492832 | Neuroscience in peripheral cancers: tumors hijacking nerves and neuroimmune crosstalk. | MedComm (2020) | 2024 | https://conductscience.org/library/papers/39492832 | PubMed |
| 39178356 | Social Genomic Determinants of Health: Understanding the Molecular Pathways by Which Neighborhood Disadvantage Affects Cancer Outcomes. | J Clin Oncol | 2024 | https://conductscience.org/library/papers/39178356 | PubMed |
| 38976162 | The multifaceted role of beta-blockers in overcoming cancer progression and drug resistance: Extending beyond cardiovascular disorders. | FASEB J | 2024 | https://conductscience.org/library/papers/38976162 | PubMed |
| 38505269 | PPARG and the PTEN-PI3K/AKT Signaling Axis May Cofunction in Promoting Chemosensitivity in Hypopharyngeal Squamous Cell Carcinoma. | PPAR Res | 2024 | https://conductscience.org/library/papers/38505269 | PubMed |
Genes15
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/37446271
GET https://conductscience.org/api/papers/v1/37446271/references?page=2